Ana Canestri

1.9k total citations
35 papers, 754 citations indexed

About

Ana Canestri is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Ana Canestri has authored 35 papers receiving a total of 754 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Infectious Diseases, 16 papers in Virology and 16 papers in Epidemiology. Recurrent topics in Ana Canestri's work include HIV Research and Treatment (15 papers), HIV/AIDS drug development and treatment (12 papers) and HIV/AIDS Research and Interventions (10 papers). Ana Canestri is often cited by papers focused on HIV Research and Treatment (15 papers), HIV/AIDS drug development and treatment (12 papers) and HIV/AIDS Research and Interventions (10 papers). Ana Canestri collaborates with scholars based in France, Cameroon and United States. Ana Canestri's co-authors include Christine Katlama, Anne‐Geneviève Marcelin, Roland Tubiana, Gilles Peytavin, Gilles Pialoux, Stéphane Jauréguiberry, Corinne Amiel, Antoine Moulignier, Vincent Cálvez and Éric Caumes and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and The Journal of Infectious Diseases.

In The Last Decade

Ana Canestri

33 papers receiving 736 citations

Peers

Ana Canestri
Sabrina Audagnotto Italy
Laura Díaz Spain
Kim Sannerud United States
Philip Ellery Australia
Saroj Bakshi United States
Alessandra Ruggiero Italy
Amy Krambrink United States
Susan Buchbinder United States
Peter Mariuz United States
Ronald B. Moss United States
Sabrina Audagnotto Italy
Ana Canestri
Citations per year, relative to Ana Canestri Ana Canestri (= 1×) peers Sabrina Audagnotto

Countries citing papers authored by Ana Canestri

Since Specialization
Citations

This map shows the geographic impact of Ana Canestri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Canestri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Canestri more than expected).

Fields of papers citing papers by Ana Canestri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Canestri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Canestri. The network helps show where Ana Canestri may publish in the future.

Co-authorship network of co-authors of Ana Canestri

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Canestri. A scholar is included among the top collaborators of Ana Canestri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Canestri. Ana Canestri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Jary, Aude, Valentin Leducq, Nathalie Désiré, et al.. (2020). New Kaposi’s sarcoma-associated herpesvirus variant in men who have sex with men associated with severe pathologies. The Journal of Infectious Diseases. 222(8). 1320–1328. 18 indexed citations
4.
Gantner, Pierre, Laurence Morand‐Joubert, Pierre Frange, et al.. (2019). “Real life” use of raltegravir during pregnancy in France: The Coferal-IMEA048 cohort study. PLoS ONE. 14(4). e0216010–e0216010. 2 indexed citations
5.
Godin, Ophélia, Antoine Moulignier, François-Xavier Lescure, et al.. (2019). Brief Report: Impact of ART Classes on the Increasing Risk of Cerebral Small-Vessel Disease in Middle-Aged, Well-Controlled, cART-Treated, HIV-Infected Individuals. JAIDS Journal of Acquired Immune Deficiency Syndromes. 81(5). 547–551. 8 indexed citations
6.
Dupont, B., et al.. (2016). Role of a NSAID in the apparent cure of a fungal mycetoma. Journal de Mycologie Médicale. 26(2). 86–93. 13 indexed citations
7.
Morbieu, Caroline, P.A. Michel, Isabelle Brochériou, Ana Canestri, & Jean‐Jacques Boffa. (2016). Néphropathie à IgA compliquée d’un syndrome néphrotique révélée par une tuberculose disséminée. Néphrologie & Thérapeutique. 12(4). 229–233. 1 indexed citations
8.
Marcy, Olivier, Sowath Ly, Chanroeurn Hak, et al.. (2016). Dyslipidemias and Elevated Cardiovascular Risk on Lopinavir-Based Antiretroviral Therapy in Cambodia. PLoS ONE. 11(8). e0160306–e0160306. 17 indexed citations
9.
Boutolleau, David, Ana Canestri, Sonia Burrel, et al.. (2012). Emergence of cytomegalovirus resistance to foscarnet in a patient receiving foscarnet salvage therapy for multidrug-resistant HIV infection. Journal of Clinical Virology. 54(2). 194–196. 7 indexed citations
10.
Canestri, Ana, Stéphane Jauréguiberry, Antoine Moulignier, et al.. (2010). Discordance Between Cerebral Spinal Fluid and Plasma HIV Replication in Patients with Neurological Symptoms Who Are Receiving Suppressive Antiretroviral Therapy. Clinical Infectious Diseases. 50(5). 773–778. 294 indexed citations
11.
Melica, Giovanna, Ana Canestri, Gilles Peytavin, et al.. (2010). Maraviroc-containing regimen suppresses HIV replication in the cerebrospinal fluid of patients with neurological symptoms. AIDS. 24(13). 2130–2133. 22 indexed citations
12.
Caby, Fabienne, Delphine Lemercier, Aurore Coulomb, et al.. (2010). Fetal death as a result of placental immune reconstitution inflammatory syndrome. Journal of Infection. 61(2). 185–188. 7 indexed citations
13.
Caby, Fabienne, Nadia Valin, Anne‐Geneviève Marcelin, et al.. (2010). Raltegravir as functional monotherapy leads to virological failure and drug resistance in highly treatment-experienced HIV-infected patients. Scandinavian Journal of Infectious Diseases. 42(6-7). 527–532. 13 indexed citations
14.
Canestri, Ana, Anne Krivine, Lambert Assoumou, et al.. (2010). Maraviroc does not affect humoral response to the pandemic influenza A-H1N1v 2009 adjuvanted vaccine in HIV-1-infected patients. AIDS. 24(18). 2887–2889. 9 indexed citations
15.
Soulié, Cathia, Slim Fourati, Sidonie Lambert-Niclot, et al.. (2010). HIV genetic diversity between plasma and cerebrospinal fluid in patients with HIV encephalitis. AIDS. 24(15). 2412–2414. 24 indexed citations
16.
Guihot, Amélie, et al.. (2009). Persistent high nevirapine blood level with DRESS syndrome 12 days after interruption of antiretroviral therapy: Figure 1. BMJ Case Reports. 2009. bcr0720080475–bcr0720080475. 4 indexed citations
17.
Soulié, Cathia, Roland Tubiana, Anne Simon, et al.. (2009). Presence of HIV-1 R5 Viruses in Cerebrospinal Fluid Even in Patients Harboring R5X4/X4 Viruses in Plasma. JAIDS Journal of Acquired Immune Deficiency Syndromes. 51(1). 60–64. 23 indexed citations
18.
Lambert-Niclot, Sidonie, Philippe Flandre, Isabelle Malet, et al.. (2008). Impact of gag mutations on selection of darunavir resistance mutations in HIV-1 protease. Journal of Antimicrobial Chemotherapy. 62(5). 905–908. 15 indexed citations
19.
Monsel, Gentiane, Ana Canestri, & Éric Caumes. (2007). Antibiothérapie de la phase primaire de la borréliose de Lyme. Médecine et Maladies Infectieuses. 37(7-8). 463–472. 3 indexed citations
20.
Bécher, François, Roland Landman, Souleymane Mboup, et al.. (2004). Monitoring of didanosine and stavudine intracellular trisphosphorylated anabolite concentrations in HIV-infected patients. AIDS. 18(2). 181–187. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sabrina Audagnotto Breakdown of academic impact, for papers by Laura Díaz Breakdown of academic impact, for papers by Kim Sannerud Breakdown of academic impact, for papers by Philip Ellery Breakdown of academic impact, for papers by Saroj Bakshi Breakdown of academic impact, for papers by Alessandra Ruggiero Breakdown of academic impact, for papers by Amy Krambrink Breakdown of academic impact, for papers by Susan Buchbinder Breakdown of academic impact, for papers by Peter Mariuz Breakdown of academic impact, for papers by Ronald B. Moss
Rankless by CCL
2026